Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs U.S. Osteoporosis Diagnostics Markets
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

U.S. Osteoporosis Diagnostics Markets

DateJun, 2001
Pages0
Price / format€3729 / Hard Copy
€3353 / Site License
€4483 / Enterprisewide

€3 325 





Abstract:



New Peripheral Technologies Drive Market Growth


As the baby boomer population ages, there will be an increased need to

accurately measure the degenerative loss of bone mass. The introduction of

peripheral bone densitometers, which measure bone density at the wrist, heel,

fingers, or forearm, will drive market growth, as non-hospital end users prefer

these faster, less expensive, portable devices to axial equipment, which

measures bone density at the hip and spine. Because peripheral technologies

are suited for non-hospital use, participants could discover new opportunities

in preventive care sectors.


This Frost & Sullivan research analyzes the markets for both axial and

peripheral densitometers, including subsegments for equipment with specific

scanning capabilities. It evaluates drivers and restraints, identifies areas with

growth potential, and provides expert forecasts. With such a comprehensive

guide to the industry, your company will be poised to optimize its resources

and enhance its bottom line.


Creating Awareness for New Products is a Top Priority


Technological innovations and improvements have surfaced that will expand

the market's offerings substantially, says the study's author. Nevertheless,

positioning these new products remains an obstacle for many manufacturers.

Without a solid promotional program, new devices often remain unknown to

healthcare institutions, and penetration is substantially diminished.

Manufacturers must educate not only hospitals and outpatient care facilities

about new technologies, but also the public about the importance of

osteoporosis screening. This research highlights emerging industry challenges,

enabling your firm to anticipate and overcome hurdles that may lie ahead.


Forging Alliances and Expanding Target Markets Should Be High Priorities


To simultaneously advocate the benefits of early screening and promote the

availability of drugs without side effects, alliances must be formed between

diagnostics manufacturers and pharmaceutical companies, says the author.

Drug companies have a vested interest in promoting early screening and

diagnosis, with the resources to mount massive marketing campaigns.


Meanwhile, densitometer manufacturers should focus their educational efforts

on new healthcare sites, including primary care facilities, pharmacies, and

other wellness centers or specialty clinics. Companies can also find new

revenue sources by creating awareness in younger populations. This study

offers strategic recommendations, helping its users formulate a plan to

optimize market dominance.











Table of contents:
- Executive Summary

- Market Overview

- Research Findings

- Total Osteoporosis Diagnostics Market

- Market Engineering Research Methodology

- Challenges Facing the Osteoporosis Diagnostics Market

- Market Engineering Strategy

- Revenue and Pricing Analysis

- Total Market Drivers and Restraints

- Market Engineering Awards

- Axial Densitometer Market

- Total Axial Market

- Market Drivers and Restraints

- Forecast and Trend Analysis

- Competitive Market/Product Analysis

- Axial DXA

- Axial QCT

- Peripheral Densitometer Market

- Total Peripheral Market

- Market Drivers and Restraints

- Forecast and Trend Analysis

- Competitive Product/Market Share Analysis

- Peripheral DXA

- Quantitative Ultrasound

- Digital/Radiographic Absorptiometry

- Peripheral QCT

- Table of Figures

- Table of Charts









Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found



Add New Buy/Sell Lead